In our biomarker identification efforts, we have reported earlier on a protein that differs in its electrophoretic mobility between mouse lines bred either for high or low trait anxiety. The altered electrophoretic behavior of enolase phosphatase (EP) is now identified to be caused by two single-nucleotide polymorphisms. In both cases, the genetic polymorphism introduces an amino acid change in the protein's sequence resulting in differential mobility on SDS gels. This was shown by recombinantly expressing the two EP isoforms. Functional studies indicate that the EP isoform from the high anxiety mouse line has a lower enzymatic activity than does its low anxiety mouse counterpart. EP is a member of the methionine salvage pathway that is responsible for the synthesis of S-adenosyl-L-methionine, a natural compound with potential antidepressant activities. In addition, it is linked to the polyamine pathway whose members have functions in anxiety/depression-related behaviors. In a freely-segregating F2 panel, both single-nucleotide polymorphisms were significantly associated with locomotion-independent trait anxiety, further supporting a functional role of EP for this phenotype. The study shows that proteomic analysis can reveal genotypic differences relevant for the phenotype. The identified protein alterations, in turn, can expose metabolic pathways pertinent to the behavioral phenotype.
Introduction
The diagnosis of anxiety and affective disorders is hampered by a dearth of molecular markers that can predict the onset or stage of the disease. Further complicating the matter is the fact that these disorders seem to be a continuum of different disease shades, and distinct phenotypes are difficult to assess by conventional means, that is the clinical interview according to DSM-IV. 1 The identification of biomarkers, which are measures of biological disease parameters, is therefore of paramount importance to make the diagnosis and classification of anxiety and affective disorders more precise and reliable. 1 We have concentrated our biomarker discovery efforts on the investigation of a selectively bred mouse model, 2, 3 as the analysis of patient specimens is plagued by a low disease marker signal to noise ratio caused by interindividual differences that are not related to the disease phenotype. Furthermore, human specimens relevant to the proteomic analysis of anxiety and affective disorders are available only in limiting amounts, and their retrieval is difficult to control in a consistent manner. This is true for both types of patient specimens relevant to these disorders, postmortem brain tissue and cerebrospinal fluid.
The establishment and examination of mouse models that reflect certain aspects of the respective human disease phenotype is therefore receiving increased attention for the identification of biomarkers. Although even for inbred mouse lines interindividual differences are observed to some extent, they are not as pronounced as in humans and hence result in a lower false-positive discovery rate in biomarker studies. In addition, the preparation of post-mortem animal tissue specimens can be carried out under controlled conditions eliminating the introduction of artificial variances.
For biomarker discovery, we have established two mouse lines with extremes in their anxiety-related phenotype. This was achieved by using an intra-strain and selective bidirectional inbreeding approach that led to an accumulation of genetic material associated with the respective anxiety phenotype. 2 The two lines, high anxiety-related behavior (HAB) and low anxiety-related behavior (LAB) mice, derived from the CD1 outbred strain, have been established as an animal model for extremes in trait anxiety using a number of behavioral paradigms. In addition to the anxiety phenotype, comorbid depression-like characteristics have been shown to differ between HAB and LAB animals. 2 Searching for anxiety biomarkers in the HAB/LAB mouse model, we initially focused our efforts on the comparative protein expression analysis by two dimensional-polyacrylamide gel electrophoresis (2D-PAGE). 2 Next to glyoxalase-1, a protein that showed a quantitative difference in its expression between HAB and LAB mice, 2 we also detected and identified a protein, enolase phosphatase (EP), which shows a qualitative difference between the two mouse lines and reveals itself by an altered mobility in the second dimension of 2D-PAGE. 3 Here, we (i) describe our efforts to elucidate the underlying moleculargenetic cause for the different electrophoretic mobility of the two EP isoforms, (ii) analyze their enzymatic activities, (iii) test the co-segregation of two single-nucleotide polymorphisms (SNPs) with phenotypic variants in a freely-segregating HABxLAB F2 intercross panel and (iv) discuss further functional implications for the anxiety-related phenotype.
Materials and methods

HAB/LAB mice
All animal breeding and behavioral studies were approved by local authorities and conducted according to current regulations for animal experimentation in Germany and in the European Union (European Communities Council Directive 86/609/EEC), and have been described earlier. 2 Briefly, all animals used in these experiments were bred and housed under standard conditions (12 h light/dark cycle, lights on at 0600 hours, at a room temperature of 23±2 1C, humidity of 60%, and tap water and food ad libitum) in the facilities of the Max Planck Institute of Psychiatry. At an age of 7 weeks, all animals were tested on the elevated plus-maze (EPM). All the mice used in this study displayed line-specific behaviors with HABs spending 7.9% and LABs spending 58.6% on the open arm of the EPM. 'Normal' anxiety-related behavior mice (NAB) were bred for intermediate anxiety-related behavior. As > 80% of CD1 mice spent between 25 and 35% of their time in the open arms of the EPM, this range was chosen for the selection of NABs without any overlaps with HAB and LAB animals. Importantly, in a wide variety of tests, the intermediate behavioral scores of NAB and CD1 mice were found to be similar if not identical. Furthermore, HAB ( > 100 s) and LAB ( < 20 s) animals differed significantly in the time spent immobile in the tail suspension test, indicative of different depression-like behavior. 2 
Proteomic analysis
Brain protein sample preparation, 2D-PAGE and mass spectrometry protein identification were carried out as described earlier. 2, 3 Brain section extracts (four each for the hypothalamus, amygdala and motor cortex from male HAB, LAB and NAB mice) representing 300 mg of protein in IEF sample buffer (7 M urea, 2 M thiourea, 0.2% biolytes 3-10, 2% CHAPS, 100 mM DTT, supplemented with the protease inhibitor cocktail 'Complete,' phenylmethylsulfonyl fluoride and pepstatin) were applied to a 17 cm, pH 4-7 Immobiline strip (BioRad, Hercules, CA, USA). After active rehydration at 50 V for 12 h, paper wicks were used and IEF was carried out at 20 1C in a PROTEAN IEF cell (BioRad) using the following conditions: 250 V for 15 min, 10 000 V for 3 h and 10 000 V until 60 000 Vh were reached. For reduction and alkylation of the proteins, the strips were equilibrated in 2% DTT for 30 min and then in 2.5% iodoacetamide for 30 min. For the second dimension, SDS-PAGE strips were layered on top of a 5% stacking gel and 12% separating gel and run in batches of 12 gels each at 50-200 V overnight. Gels were stained with colloidal Coomassie Blue and scanned. The scanned images were analyzed and compared with each other with the help of PDQUEST software (BioRad). Spots representing an altered electrophoretic mobility were detected using the automated spot detection and matching function. After normalization according to total density, spot intensities were quantitated and compared between the replicate groups (HAB, LAB, NAB). The automated analysis was completed by manual matching and quantitation of spots of interest. For the in-gel tryptic digest, 50 ml 20 mM ammonium bicarbonate/acetonitrile (1:1) was used for gel cleanup and drying. After the gel pieces were dry, 30 ml 20 mM ammonium bicarbonate containing 0.5 mg trypsin (Promega, Madison, WI, USA) was added and incubated at 37 1C overnight. Peptides were extracted twice with 25 ml 5% formic acid by incubation at 37 1C for 30 min. The extracts were concentrated in a speedvac and redissolved in 12 ml 0.1% formic acid. For mass spectrometry analysis, the tryptic digests were injected onto a C18 cartridge using a FAMOS Autosampler (Dionex, Sunnyvale, CA, USA). After washing the cartridge with 0.1% formic acid (solvent A) for 15 min, the peptides were eluted onto a Picofrit column (New Objectivce, Woburn, MA, USA) by applying a linear gradient of acetonitrile/water/formic acid (90:10:0.1) over 60 min. The Picofrit eluate was infused directly into an LCQ DECA XP PLUS iontrap mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA). Each full scan was followed by a zoom scan and an MS/MS scan of the most intense signal. The resulting MS/MS data were used to search a non-redundant protein database, release date 25 July 2003, (NCBI, Bethesda, MD, USA), using TURBOSEQUEST (J. Yates, III, and J. Eng, University of Washington, Seattle, WA, USA). Mass spectrometry identifications were considered positive when a minimum of three peptides resulted in the same protein hit.
Western blot
Fifty mg of total protein from HAB and LAB brain extracts or 1 mg of affinity-purified recombinant EP were run on a 15% SDS mini gel (BioRad) and the proteins transferred to an Immobilon PVDF membrane (Millipore, Bedford, MA, USA) at 100 V for 1 h with cooling. The membrane was treated with 5% Carnation instant nonfat dry milk (Nestle USA, Wilkes-Barre, PA, USA) in Tris-buffered saline Tween-20 (TBST) overnight and rinsed in TBST. The membrane was then incubated with an EP-specific antibody (MorphoSys, Martinsried, Germany) at a 1:2000 dilution in TBST for 2 h at room temperature and washed with water and TBST for 15 min. Incubation with an anti-c-myc-peroxidase antibody (Roche Diagnostics, Indianapolis, IN, USA) was carried out for 40 min at room temperature after which the membrane was washed with TBST. Finally, the membrane was incubated with ECL mixture (GE Healthcare BioSciences Corp., Piscataway, NJ, USA) for 1 min and exposed to ECL film (GE Amersham Biosciences). 3 Enolase phosphatase expression analysis Cortex tissue from six male HAB, LAB and NAB mice each was immediately frozen in liquid nitrogen and ground into fine powder under liquid nitrogen using a mortar and pestle. A maximum amount of 30 mg frozen tissue powder was then transferred into an RNase-free liquid-nitrogen-cooled collection tube, and 600 ml lysis RLT buffer from the RNeasy Mini Kit (Qiagen, Hilden, Germany) was added. Homogenization was performed using QIAshredder spin columns (Qiagen) by transferring the tissue suspension into a 2 ml collection tube and spinning it for 2 min at 14 000 r.p.m. in a microcentrifuge. The lysate was homogenized as it passed through the spin column. The supernatant was then removed and transferred to a new microcentrifuge tube. One volume of 70% ethanol was added to the clear lysate and mixed immediately by repeated pipetting. RNA extraction was then performed with an RNeasy spin column according to the manufacturer's instructions (Invitrogen, San Diego, CA, USA). cDNA synthesis and PCR were performed using the SuperScript One-Step RT-PCR with the help of the Platinum Taq system (Invitrogen). Reverse transcription and PCR were performed using EP-specific primers (sense primer: 5 0 -GTGTTGCCCTCCTTAACCA-3 0 ; antisense primer: 5 0 -GGTCTTCATGGAACGGACA-3 0 ), 1 mg of template RNA and an enzyme mix of SuperScript II Reverse Transcriptase and Platinum Taq DNA Polymerase (Invitrogen).
One cycle of cDNA synthesis at 50 1C for 30 min was followed by 37 cycles of denaturation at 94 1C for 15 s, annealing at 60 1C for 30 s, and extension at 70 1C for 1 min kb
À1
. One final extension cycle was performed at 72 1C for 10 min. Amplification products were visualized with the help of agarose gel electrophoresis and staining with ethidium bromide. The 996 kb PCR products were confirmed by DNA sequencing (Medigenomix GmbH, Martinsried, Germany).
Recombinant enolase phosphatase expression
Cortices were retrieved from HAB and LAB mice and total RNA was extracted using the RNeasy Mini kit according to the manufacturer's instructions (Qiagen). Total RNA (500 ng) was reverse transcribed into cDNA by SuperScript III One-Step RT-PCR Platinum Taq HiFi kit (Invitrogen). The following primers (Thermo Fisher Scientific, Ulm, Germany) based on the EP DNA sequence were used for PCR, which was carried out in a gradient cycler (MJ Research, Waltham, MA, USA): sense primer: 5 0 -ATGGTAGGTCTCAGCGCAT GGTCGTGGTTTCCGTGCCC-3 0 ; antisense primer:
The pASK-IBA-7plus vector (IBA BioTAGnology, Göttingen, Germany) and PCR products were digested with the BsaI restriction enzyme (New England BioLabs, Ipswich, MA, USA), and the PCR products were cloned into the vector using the Rapid DNA Ligation Kit (Fermentas, St Leon-Ro, Germany). The recombinant vector was then transformed into one shot OmniMAX 2T1 Phage-resistant competent cells (Invitrogen). Plasmid DNA was purified using the Plasmid Mini kit (Qiagen). The clones were sequenced (Sequiserve GmbH, Vaterstetten, Germany) and then transformed into BL21 Star (DE3) One Shot competent cells (Invitrogen). Expression, affinity purification and cleavage of the StrepTag-EP fusion proteins with factor Xa were carried out according to the manufacturer's instructions (IBA BioTAGnology).
Enzymatic assay
The enzymatic activity was measured by using the EP substrate analog 1-phosphonooxy-2,2-dihydroxy-3-oxohexane (InnoChemie GmbH, Wü rzburg, Germany) described by Zhang et al. 4 The formation of the acidoreductone reaction product was monitored by UV spectroscopy at 305 nm as described. 4 Polyamine assay One hundred mg brain homogenate from HAB and LAB animals (see above) were treated with 200 ml 0.4 M perchloric acid and sonicated (40 W, 20-30 s) and the polyamines extracted overnight at 4 1C. After centrifugation at 10 000 g for 20 min, the supernatants were aspirated and the polyamines benzoylated as described. 5 Briefly, 300 ml of NaOH and 3 ml of benzoyl chloride were added to 100 ml of extract, mixed and incubated for 20 min at room temperature. The reaction was stopped by the addition of 500 ml of a saturated NaCl solution.
Polyamines were extracted in 500 ml chloroform, and after centrifugation at 10 000 g for 10-20 min, the chloroform layer was collected, evaporated to dryness, and redissolved in 100 ml 55% methanol. The derivatized polyamine extracts were separated on an 1100 Series HPLC system (Agilent Technologies, Waldbronn, Germany). For this purpose, 20 ml aliquots were injected onto an EC 250/2 Nucleosil 300-5 C18 column (Machery-Nagel, Dü ren, Germany). The mobile phases were A: water and B: methanol with a gradient of 55-84% methanol over 23 min followed by isocratic elution at 84% methanol for 7 min at a flow rate of 0.2 ml min À1 . Derivatized
Trait anxiety pathways C Ditzen et al polyamines were monitored at 254 nm and quantitated on the basis of putrescine, spermidine and spermine standards (Sigma Aldrich, St Louis, MO, USA) of known amounts. For this purpose, the area of the UV signal peak was calculated.
F2 panel
Single-nucleotide polymorphisms were assessed using a custom-designed oligonucleotide pool for analysis on a Sentrix Array Matrix platform (Illumina, San Diego, CA, USA). In the parental generation, the two polymorphisms located in the coding sequence of Enoph1 display opposite homozygosity in HABs (GG and CC) vs LABs (AA and TT). A total of 514 F2 offspring of a HABxLAB intercross (F1) progeny were phenotyped (anxiety-related behavior: EPM; locomotor activity: EPM and open field; depression-like behavior: tail-suspension test; for a more detailed description of behavioral tests see Krö mer et al. 2 ) and genotyped at these two loci on the basis of DNA isolated from tail tips as described by Keler et al. 6 Genotyping was performed using the manufacturer's protocol and genotypes were calculated using the BeadStudio software 3.1.0.0 and the Genotyping Module 3.1.12 (Illumina). Twenty-four samples were tested repeatedly, assuring data quality and reproducibility.
Statistical analysis
Statistical analysis was performed using WG-Permer (http://www.mpipsykl.mpg.de/wg-permer). Trait values were rank-transformed to protect against artifacts. Analysis was carried out using a genotypic model, that is, the three genotypic classes possible for each of the phenotypes were treated as a separate class each, and a global test on equality of the three means was performed.
Results
Two dimensional-PAGE image analysis of the amygdala, cortex and hypothalamus extracts from HAB, LAB and NAB animals for qualitative protein differences revealed an altered migration pattern for EP indicating either a post-translational modification or an allelic difference (Figure 1) . 3 In HAB animal brain tissue extracts, the EP protein isoform shows a lower mobility in the second SDS-PAGE dimension than for LAB and NAB mice. At the same time, no significant difference was observed in the EP protein spot intensity OD values between the three mouse lines in the amygdala (HAB: 0.16, LAB: 0.12, NAB: 0.14), cortex (HAB: 0.14, LAB: 0.08, NAB: 0.08) and hypothalamus (HAB: 0.23, LAB: 0.17, NAB: 0.18) (Figure 1 ). 3 The EP proteins were identified by cutting out the stained gel spots from HAB, LAB and NAB animals, and by subjecting the proteins to in-gel digestion with trypsin followed by tandem mass spectrometry. Mass spectrometry data were used to search the non-redundant protein database, which resulted in the identification of EP for all three mouse strains.
The following peptide sequences were identified from the tryptic digests of the gel spots:
HAB: VYIYSSGSVEAQK, VDSESYR, PGNAGLTDDEK LAB: QLQGHMWK, AAFTAGR, VDSESYR, PGNAGL TDDEK NAB: QLQGHMWK, AAFTAGR, VDSESYR, PGNAGL TDDEK.
To determine the cause of the observed difference in 2D-PAGE migration, mRNA from six HAB and LAB mouse brains each was isolated for cDNA sequence analysis. Two SNPs, rs13460000 and rs13460001, were identified to differentiate between the HAB and LAB cDNA sequences (Figure 2 ), and they are published in the NCBI mouse SNP database (http://www.ncbi.nlm.nih.gov/SNP).
Both SNPs show the opposite homozygous state in HAB vs LAB mice and are non-synonymous in nature, that is, cause amino-acid substitutions in the EP protein sequence. One amino acid change caused by SNP rs13460000 is conservative (isoleucine to valine), whereas the other change caused by SNP rs13460001 represents a non-conservative alteration with a leu- cine replaced by a proline residue in the HAB animals ( Figure 2 ).
To prove that the altered amino-acid sequences of the EP isoforms are the cause of their different mobility in SDS gels, we expressed the two EP isoforms as recombinant proteins in bacteria. For this purpose, the cDNAs encoding the full-length EP protein isoforms were ligated into an expression vector that produced EP fusion proteins with an eight amino acid StrepTag at their amino-terminal ends. After expression and affinity isolation, the StrepTag was cleaved off, resulting in full-length EP protein isoforms. Both isoforms were then subjected to western blot analysis, which showed that the recombinant HAB EP protein isoform has indeed a lower mobility than does the recombinant LAB protein isoform (Figure 3a) emulating the electrophoretic behavior of the native mouse brain proteins (Figure 3b) .
On the basis of only a subtle difference in the predicted molecular weight between the two EP isoforms, it is surprising to observe an altered mobility in denaturing SDS gel electrophoresis. We speculate that the two amino acid changes in the HAB EP protein result in a slightly different structure, possibly unfolding the protein and causing its lower mobility during SDS gel electrophoresis. This kind of behavior is also frequently found when protein intrachain disulfide bonds are cleaved, which results in an unfolding of the protein chain and slower mobility in SDS gels. Apparently, the anionic detergent SDS does not always completely denature/ unfold protein chains and can lead to non-standard behavior during SDS gel electrophoresis.
As a member of the methionine salvage pathway, the EP enzyme catalyzes through an enolization and dephosphorylation mechanism the conversion of the 1-phosphonooxy-2,2-dihydroxy-3-oxo-5-methylthiopentane intermediate to acidoreductone. 4 To find out whether the two EP isoforms differ in their enzymatic activity, we used the EP substrate analog 1-phosphonooxy-2,2-dihydroxy-3-oxohexane and monitored the formation of the acidoreductone reaction product by UV spectroscopy. 4 The recombinant HAB EP isoform shows a lower turnover rate as compared with the LAB isoform as is evident from the lower absorption values at OD 325 that reflect the formation of the enzymatic reaction product acidoreductone (Figure 3c ). This result was confirmed when the Michaelis-Menten constants for the two EP isoforms were calculated from a Lineweaver-Burk plot (LAB EP isoform K M = 1.38 mM; HAB EP isoform K M = 4.34 mM).
On the basis of the altered enzymatic activity of the HAB EP isoform and the link between the methionine salvage pathway, of which EP is a member, and the polyamine pathway, 7, 8 we decided to investigate polyamine levels in our mouse strains. Figure 4 shows the results from this analysis for putrescine, spermidine and spermine. All three polyamines have elevated levels in the brains of HAB compared with LAB animals, with the putrescine and spermidine differences showing statistical significance (Figures 4a and b) . Accordingly, the concentrations of both putrescine (r = À0.78, P = 0.003) and spermidine (r = À0.69, P = 0.013) but not spermine (r = À0.31, P = 0.34) were found to correlate negatively with % time spent on open arms.
To further test their functional involvement, the EP SNPs were analyzed in a freely segregating F2 panel. In a total of 514 male mice, 111 animals were identified as carrying the HAB-typical SNPs rs13460000 and rs13460001 (GG and CC), 116 animals the LAB-typical AA and TT, and 287 animals the heterozygous AG and CT genotypes. If these SNPs affect anxiety-related behavior, homozygous GG and CC F2 animals should behave more anxiously than do their AA and TT counterparts. Indeed, a co-segregation could be detected with the AA and TT mice being significantly less anxious on the EPM (Figure 5a) . Importantly, the association between the SNPs and anxiety levels was independent of locomotor activity measured in two independent tests (Figures 5c and d) . In contrast to anxiety-related behavior, depression-like behavior did not differ among the three groups (Figure 5b) .
The genotypic test for anxiety-related behavior was highly significant for each of the two SNPs with a P-value at 1.06 Â 10 À6 and genotypic distribution explaining 5% of the variance of the ranks of the trait. Depression-like behavior, by contrast, showed no such co-segregation; locomotor activity in the open field was nominally significant (P = 0.04). However, after correcting the locomotor phenotype for the anxiety-related phenotype, this association was completely removed (P = 0.31; Figure 5d ).
Discussion
In this study, we report on two non-synonymous variants for the EP gene in HAB mice that result in a protein isoform (Figure 2 ) with lower SDS gel mobility and enzymatic activity ( Figure 3) . As shown in a freely-segregating F2 panel, both SNPs were significantly associated with locomotion-independent trait anxiety, supporting a functional role for EP for this phenotype.
Enolase phosphatase is a member of the methionine salvage pathway, where methionine is metabolized to S-adenosyl-L-methionine (SAM), a compound described as a natural mood-stabilizer and antidepressant in clinical studies. 9, 10 Several mechanisms of SAM's antidepressant activity are being discussed. SAM is an important methyl group donor in a number of cellular processes including the formation of epinephrine from norepinephrine and sarcosine from glycine, thereby influencing neurotransmitter levels. In addition, the synthesis and inactivation of the monoamines serotonin, dopamine and histamine require SAM-dependent methylation reactions. The methylation of DNA cytosine residues inhibits transcription and represents an important epigenetic mechanism that is receiving increased attention in the affective disorder field.
11 SAM also influences the fluidity of cell membranes, as it is required for methylation of phosphatidylethanolamine and its conversion to phosphatidylcholine. The ratio of phosphatidylethanolamine and phosphatidylcholine determines the fluidity of a membrane, and a decrease in membrane viscosity facilitates the lateral movement of proteins, including receptors. 12 The restored membrane phospholipid methylation may play a role in SAM's antidepressant effect. Figure 3 Western blot analysis of recombinant (a) and native (b) high anxiety-related behavior (HAB) and low anxietyrelated behavior (LAB) protein isoforms. In both cases, the HAB protein migrates slower compared with the LAB protein.
Enzymatic assay of HAB and LAB protein isoforms recombinantly expressed in bacteria (c). The enzyme kinetics are monitored by the conversion of the substrate analog 1-phosphonooxy-2,2-dihydroxy-3-oxohexane to acidoreductone by the two enolase phosphatase (EP) isoforms. 4 The HAB EP isoform shows a lower turnover rate as compared with the LAB isoform.
Through the synthesis of S-adenosylhomocysteine, which is rapidly metabolized to homocysteine in SAM-dependent methylation reactions, SAM is linked to the transsulfuration pathway that leads to the synthesis of glutathione. Glutathione is one of the major antioxidants in the human body, and oxidative stress has been implicated in a number of brain disorders, including Alzheimer's Disease and major depression. [13] [14] [15] [16] [17] [18] Homocysteine, which is converted to methionine, is part of a reaction that requires methyltetrahydrofolate as a methyl group donor. States of folate deficiency have been shown to lower brain SAM levels and result in hypomethylation. 19 Depression is a common neuropsychiatric manifestation of severe folate deficiency, and surveys of the folate status of depressed patients have revealed that up to one-third of inpatients have folate deficiency. 20, 21 Depressed patients in whom folate deficiency was corrected showed better symptomatic recovery and less time spent in hospital. 22 In summary, by serving as a donor of a methyl group that improves the methylation state of a number of brain molecules, SAM might be able to compensate for folate deficiency and improve depressive symptoms.
S-adenosyl-L-methionine is also known to be involved in the biosynthesis of the polyamines spermine and spermidine by transferring its aminopropyl group to putrescine. 7, 8 In this context, the results in an animal model for depression have shown that the levels of the three polyamines are altered in specific brain areas compared with control animals and that SAM administration can modulate polyamine levels. 23 Although polyamines have been proposed as potential antidepressant agents, only a limited number of studies on their analyses in brain tissue and cerebrospinal fluid have been reported so far and the available data are inconsistent. In one study, decreased expression levels of spermidine/ spermine N-acetyltransferase in the cingulate gyrus were found in suicide completers with depression. 24 Analyses using frontal cortex and hippocampus did not reveal any alterations in polyamine levels or related pathway enzymes in depressed patients. 25 The analysis of polyamines in serum or plasma specimens are compromised, as putrescine, spermidine and spermine have only a limited capacity to cross the blood-brain barrier and peripheral levels do not reflect those in the central nervous system. 26 Polyamines exert potent effects on neurotransmission because of their modulation of different types of ion channels, including the N-methyl-D-aspartatetype excitatory amino-acid (NMDA) receptor and the a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor. 27 Although we provide correlative evidence for an involvement of both putrescine and spermidine in the HAB/LAB mouse model, we do not have any evidence yet for the involvement of NMDA and AMPA receptors in the HAB/LAB phenotype. Both receptors play important roles in glutamatergic neurotransmission and have been associated with a variety of mental processes including long-term potentiation, neuronal development and neuronal plasticity 28 as well as affective disorder pathobiology. 29 The link between the methionine salvage pathway, of which EP is a member, and the polyamine pathway 7, 8 prompted us to analyze the levels of putrescine, spermidine and spermine in the brains of HAB and LAB animals. Significantly increased Figure 4 Polyamine assay of male high anxiety-related behavior (HAB) and low anxiety-related behavior (LAB) brain tissue extracts (n = 6 each). Putrescine (a), spermidine (b) and spermine (c) levels were measured after derivatization with benzoyl chloride followed by high-performance liquid chromatography analysis. Putrescine and spermidine differences are statistically significant (one-way analysis of variance, **P < 0.01).
amounts of putrescine and spermidine were found in HAB relative to LAB mice (Figure 4) . Further supporting the functional relevance of these data, the preliminary evidence indicates that repeated administration of diazepam exerted effects on both anxiety-related behavior and polyamine levels in HAB pups on postnatal day 5, when these animals are susceptible to pharmacological treatment. 2 Specifically, the number of ultrasound vocalization calls, indicative of reduced anxiety, was found decreased after treatment, and coincided with diminished levels of putrescine, spermidine and spermine in the pups' brains (data not shown).
Although we do not have any evidence yet, one can speculate that the reduced EP activity affects the synthesis of the polyamines in HAB mice. One explanation of how a lower EP activity could influence putrescine and spermidine levels is the accumulation of the EP substrate, diketo-methylthiopentylphosphate, which could trigger a feedback mechanism that leads to increased synthesis rates of the polyamines, a hypothesis that needs to be confirmed in future studies.
Owing to the comorbidity of anxiety and depression and the high probability of shared underlying neuronal circuits, 30 ,31 the lower enzymatic activity of the HAB EP isoform is quite likely involved in the pathophysiology of the HAB phenotype. To test this hypothesis, an F2 panel, where both genotypes and phenotypes can freely segregate, was used as a means to identify functional associations between genetic and phenotypic features. 6, [32] [33] [34] [35] In this study, we were able to show that the two SNPs in the EP gene quite likely contribute to both enzymatic activity and phenotype. Indeed, AA and TT mice spent significantly more time on the open arms of the EPM than did their GG and CC counterparts, thus confirming the hypothesized association between the SNPs, the EP isoform enzymatic activity, the metabolic consequences and their functional contribution to the phenotype. Importantly, we were able to show that the co-segregation of genotype and phenotype is independent of locomotor activity, which often contaminates anxiety-related behavior. 2 The latter is a polygenic, multifactorial trait presumed to have a complex inheritance and to involve the interaction of multiple genes with epigenetic and environmental factors. 31, 33, 34 It is therefore quite remarkable that F2 animals adopt an anxiety-related behavior if their genetic constellation at the EP loci is HAB-like, that is, homozygous GG and CC (Figure 5a) . A stronger association can probably not be expected for two SNPs in a single gene and explains why heterozygous (that is, AG and CT) F2 mice did not show strictly A major goal in the area of mental disorders is the identification of biomarkers that can categorize subsets of subjects in a more reliable and consistent manner. 1 Our approach shows that the combined proteomic and molecular genetic analyses in a robust and valid animal model can result in biomarker candidates that are part of metabolic pathways pertinent to the disease phenotype. On the basis of an altered mobility in a 2D-PAGE analysis, we have identified a protein biomarker that is differentially expressed in CD1 mice with different genetic predispositions to anxiety-related behavior. In this case, the differential mobility of EP in HAB vs LAB animals is due to two SNPs that result in different protein isoforms and enzymatic activities. Remarkably, the EP genotype in an F2 panel was shown to co-segregate with the anxiety phenotype and it provides valuable information with regard to the pathways that are involved in trait anxiety. In other words, genetic differences identified in an animal model can not only lead to biomarker assays that assess altered protein expression, but at the same time it can reveal differences in functionally relevant metabolite levels.
As even QTL in mice are responsible only for a small proportion of the genetic variance in anxiety, 33, 6 we cannot be certain that the SNPs described here will translate into candidate markers for human traits. It also remains to be shown whether the pathway knowledge gained from the proteomic analysis in a mouse model can be used for the examination of specimens from patients afflicted with anxiety and affective disorders. As differences in the EP gene may not be associated with trait anxiety in patients, it is far more promising to interrogate the pathway that EP is a part of for a possible dysfunction causing the anxiety phenotype in patients. We therefore propose that the examination must not be restricted to the candidate protein marker that was initially identified in the animal model but that it should also include many, if not all, members of the pathway, of which the protein is a member, and be further extended to other pathways that are associated. Future studies with a great number of human case and control specimens will tell whether metabolites from the methionine salvage and/or polyamine pathways can be used in the diagnosis of anxiety or affective disorders in patients or even as potential targets for psychopharmacology.
